TORONTO and AACHEN, Germany, Feb. 24, 2025 /PRNewswire/ – Apotex Inc. (“Apotex”), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management and related diseases, announced today that they have entered into a strategic licensing agreement whereby…
